ESR1 and benign prostatic hyperplasia: Overall, these findings underscore the need for further studies into how racial differences in steroid hormone signaling between EA and AA men influence the progression, severity, and therapeutic responsiveness to selective estrogen receptor modulators of LUTS/BPH.